BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer

Also known as: Platinum-sensitive Recurrent BRCA Wild Type Ovarian Cancer

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB00112	Bevacizumab	2	Enrolling by Invitation	1
DB09074	Olaparib	2	Enrolling by Invitation	1
DB09074	Olaparib	2	Recruiting	1
DB09037	Pembrolizumab	2	Enrolling by Invitation	1